Research Publications

Malaria Vaccine Efficacy in Sub-Saharan Africa: R21/Matrix-M Field Trial

The R21/Matrix-M malaria vaccine demonstrated 74–77% efficacy against clinical malaria in African children aged 5–36 months in a Phase IIb trial across four Sub-Saharan African countries. This study p...